Sponsored
Article Tools

Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe

Published: February 12, 2013; 08:04 · (Vindobona)

Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe

Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe / Picture: © Vindobona Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Company Information

Wien (euro adhoc) - Vienna (Austria), February 12, 2013 - Intercell AG (VSE;
"ICLL") announced today that the pediatric indication for IXIARO®, a vaccine to
protect against Japanese Encephalitis (JE),…

This article includes a total of 644 words.

or Log In

Fast News Search
Read More
ISIN
AT0000612601